Seeking Alpha

Celgene (CELG) is one of two firms other than GSK that are considering buying Human Genome...

Celgene (CELG) is one of two firms other than GSK that are considering buying Human Genome (HGSI) and are holding talks with the company, Reuters reports. There's no word on who the second suitor is, although any deal would most likely be a merger of equals. With Human Genome holding an auction, the deadline for bids is July 16.
Comments (1)
  • Todd Johnson
    , contributor
    Comments (6952) | Send Message
     
    $GSK owns $HGSI. $CELG is supposed to be stacked with their own drugs,no?
    8 Jul 2012, 07:55 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|